Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of IDN-6556 in Subjects With Liver Cirrhosis

ClinicalTrials.gov ID: NCT02230670

Public ClinicalTrials.gov record NCT02230670. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 4:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Subjects With Liver Cirrhosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter study to see if treatment with IDN-6556 can help improve the liver function of patients with liver cirrhosis with Model for End-Stage Liver Disease scores between 11-18.

Study identification

NCT ID
NCT02230670
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Conatus Pharmaceuticals Inc.
Industry
Enrollment
87 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2014 (Type not available)
Primary completion
Jan 2016 (Actual)
Completion
Jan 2016 (Actual)
Last update posted
Jul 5, 2017

2014 – 2016

United States locations

U.S. sites
28
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
Scripps Clinic La Jolla California 92037 —
Loma Linda University Medical Center Loma Linda California 92354 —
Cedar-Sinai Medical Center Los Angeles California 90048 —
Univeristy of California, San Diego San Diego California 92093 —
California Pacific Medical Center San Francisco California 94115 —
University of Florida Gainesville Florida 32610 —
University of Miami Miami Florida 33136 —
Piedmont Atlanta Hospital Atlanta Georgia 30309 —
University of Chicago Chicago Illinois 60637 —
Loyola University Medical Cente Maywood Illinois 60153 —
Indiana University Indianapolis Indiana 46202 —
University of Louisville Louisville Kentucky 40202 —
Henry Ford Hospital Detroit Michigan 48202 —
Rutgers New Jersey Medical School Newark New Jersey 07103 —
North Shore University Hospital Manhasset New York 11030 —
NYU Medical Center New York New York 10016 —
Mt. Sinai School of Medicine New York New York 10029 —
University of Cincinnati Physicians Company, LLC Cincinnati Ohio 45267 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Einstein Healthcare Network Philadelphia Pennsylvania 19141 —
Baylor All Saints Medical Center Fort Worth Texas 76104 —
Baylor College of Medicine Houston Texas 77030 —
Baylor St. Luke's Medical Center Houston Texas 77030 —
UT Health Science Center at Houston Houston Texas 77030 —
University of Utah Hospital Salt Lake City Utah 84132 —
Bon Secours Mary Immaculate Hospital Newport News Virginia 23602 —
Bon Secours St. Mary's Hospital of Richmond, Inc. Richmond Virginia 23226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02230670, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2017 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02230670 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →